Fanconi anemia (FA) is a unique DNA damage repair pathway. Almost twenty-two genes have 13 been identified which are associated with the FA pathway. Defect in any of those genes causes 14 genomic instability, and the patients bear the mutation become susceptible to cancer. In our 15 earlier work, we have identified that Fanconi anemia protein G (FANCG) protects the 16 mitochondria from oxidative stress. In this report, we have identified eight patients having 17 mutation (C.65G>C; p.Arg22Pro) in the N-terminal of FANCG. The mutant protein 18 hFANCGR22P is able to repair the DNA and able to retain the monoubiquitination of FANCD2 19 in FANCGR22P/FGR22P cell. However, it lost mitochondrial localization and failed to protect 20 mitochondria from oxidative stress. Mitochondrial instability in the FANCGR22P cell causes the 21 transcriptional down-regulation of mitochondrial iron-sulphur cluster biogenesis protein Frataxin 22 (FXN) and resulting iron deficiency of FA protein FANCJ, an iron-sulphur containing helicase 23 involved in DNA repair. 24 25 26 27 28 29 30 31 32 33 34 65 head and neck cancer (Rosenberg et al., 2005). To date, twenty two genes have been identified 66 that associate with FA that are primarily involved in a specific type of DNA damage repair; inter-67 strand crosslink (ICL) repair. ICL is caused by the exogenous alkylating agents or endogenous 68 130 tracker (pDsmito-Red) was used in these co-localization studies. Each deletion construct 131 including a wild type control was transiently expressed along with mito-tracker in HeLa cells. The 132 expression of both the constructs was analyzed by deconvolution microscope (Axio Observer.Z1, 133
Introduction 35 Nuclear genomic instability is a common phenomenon and prerequisite for cancer. Genomic 36 stability is maintained by the balance between the rate of DNA damage and rate of repair. Non 37 repairable damage of the genome or genomic mutation may cause loss of heterozygosity (LOH), 38 may activate proto-oncogenes, may inactivate tumor suppressor genes and/or can alter the 39 regulation of genes associated with cell cycle and cellular signals (PC, 1976; Philpott et al., 1998 ; 40 Veatch et al., 2009). These DNA damaging agents are either exogenous or endogenous. The most 41 abundant endogenous DNA damaging agents are oxidative radicals which are produced primarily 42 by mitochondria. Several studies suggest that one of the causes of genomic instability is the 43 overproduction of reactive oxygen species (ROS) resulting from mitochondrial dysfunction 44 (Vives-Bauza et al., 2006) . When the extent of irreparable damage is extensive, then the cell 45 undergoes apoptotic death, a normal phenomenon which is controlled by mitochondria (Kujoth et 46 al., 2005) . Therefore, the mitochondrion's role in malignancy is considerable because in addition 47 to critical changes in metabolism mitochondria determine the balance between survival and death. 48 However, the precise mechanism of how mitochondria maintain nuclear genomic stability is not 49 clearly known. Alterations of both the mitochondrial and nuclear genomes have been observed in 50 various types of cancers (Larman et al., 2012) . In yeast, an association of mitochondrial function 51 with genomic DNA integrity has been reported (Flury et al., 1976) . Recently, it has been shown 52 that under certain conditions, mitochondrial caspase may lead to nuclear DNA damage and 53 genomic instability (Ichim et al., 2015) . Daniel E. Gottschling's group created a specific mutant 54 strain of S cerevisiae and showed that genomic stability is maintained by iron-sulphur cluster 55 synthesis, an essential mitochondrial function (Veatch et al., 2009 ). Loss of mitochondrial 56 membrane potential causes downregulation of iron-sulfur cluster (ISC) biogenesis, an essential 57 mechanism for the Fe-S domain containing proteins involved in nuclear genomic stability (Kispal 58 et al., 1999). However, this observation requires further studies to identify human pathogenic 59 mutants that might be involved in the process. 60 In this report, we have explored this hypothesis by describing the mutation of a FA patient 61 subtype G (FANCG). FA is a rare, hereditary, genomic instability and cancer susceptibility 62 syndrome. Congenital disabilities and bone marrow failure are the most prominent features of FA 63 patients. After consecutive bone marrow transplantation (BMT), patients suffer from BMT-64 associated problems and undergo increased cancer risk, including hematological malignancies and metabolites such as formaldehydes and acetaldehydes (Bluteau et al., 2016) . Upon damage, out of 69 twenty two, eight proteins (A, B, C, E, F, G, L & M) form a complex which is called the FA core 70 complex (Walden and Deans, 2014) . The FA core complex formation initiates the 71 monoubiquitination of both FANCD2 and FANCI, which is called the ID2 complex. The ID2 72 complex binds the damaged part of the chromatin and in association with other FA proteins and 73 non-FA proteins repair the ICL damage. The repairing complex mostly consists of several 74 exonucleases, endonucleases, helicases, and proteins involved in the DNA damage repair by 75 homologous recombination pathway (Walden and Deans, 2014) . 76 FANCJ is a DEAH superfamily 2 helicase and part of the subfamily of Fe-S cluster-containing 77 helicase-like proteins including XPD, RTEL1, and CHL1 (Guo et al., 2016) . FANCJ cells are 78 highly sensitive to ICL agents, and mutation studies suggest its association with cancer (Brosh 79 and Cantor, 2014). Many genetic and biochemical studies suggest FANCJ is an ATP dependent 80 helicase which unwinds the duplex DNA or resolves G-quadruplex DNA structures (Guo et al., 81 2014). Thus, FANCJ has an essential role in ICL damage repair and in maintaining genome 82 stability. Recently, it has been shown that a pathogenic mutation in that iron-sulphur (Fe-S) 83 cluster is essential for helicase activity and iron deficiency results in the loss of helicase activity 84 of the FANCJ but not the ATPase activity (Wu et al., 2010) . 85 The sensitivity of the FA cell to the oxidative stress and several protein-protein interaction studies 86 suggest that FA proteins are also involved in oxidative stress metabolism (Mukhopadhyay et al., 87 2006). In our earlier studies, we have shown that FA subtype G (FANCG) protein interacts with 88 the mitochondrial protein peroxiredoxin 3 (PRDX3), a member of the peroxidase family and 89 neutralizes the mitochondrial oxidative stress. In FANCG cells PRDX3 is cleaved by calpain 90 protease and loses its peroxidase activity. Elevated oxidative stress alters the mitochondrial 91 structure and loss of mitochondrial membrane potential was observed in the FANCG cells 92 (Mukhopadhyay et al., 2006) . These results suggest that FANCG protects the mitochondria from 93 oxidative stress by preventing the PRDX3 from calpain-mediated degradation. Many groups 94 including our own have debated the role of FA proteins in mitochondria (Pagano et al., 2014) . In 95 this report, we have identified the N-terminal thirty amino acids, which is unique to humans as the 96 mitochondrial localization signal (MLS) of FANCG. Human mutation studies confirmed both the 97 nuclear and mitochondrial roles of FANCG. The objective of the current study was to identify the 98 defect of FANCJ in mutant cells due to oxidative stress-mediated mitochondrial dysfunction. In 99 conclusion, we showed that specific mutations in the mitochondrial localization signal in FANCG 100 result in mitochondrial dysfunction result in genomic instability.
Results
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Identification of Mitochondrial Localization Signal (MLS) of human FANCG
103
In our earlier studies, we have shown that human FANCG protein protects the mitochondrial 104 peroxidase PRDX3 from calpain cleavage and subsequently mitochondria from oxidative 105 stress (Mukhopadhyay et al., 2006) . Since FA proteins are known to regulate nuclear DNA 106 damage repair (DDR), this brings up the question of how the FANCG protein migrates to 107 mitochondria. Of the thousands of nuclear proteins that migrate to mitochondria (Backes et al., 108 2018) some have been shown to have mitochondrial localization signals. However, many of them 109 do not have an identifiable signal peptide. Generally proteins migrate to mitochondria through the 110 interaction of TOM (mitochondrial outer membrane protein) and TIM (mitochondrial inner 111 membrane protein) and some proteins enter with the help of carrier proteins (Nickel et al., 2018) . 112 Human FANCG contains a TPR motif (tetratricopeptide repeat) which is known to facilitate 113 protein-protein interaction (Wilson et al., 2010) . Initially, we thought that FANCG might interact 114 with some TPR-containing TOM proteins. However, immuno-precipitation (IP) studies did not 115 support this idea (data not shown). 116 There are several online tools available, which can be used for identification of the signal peptide 117 sequence for protein cellular localization. Similarly, some specific tools are also available for 118 identification of mitochondrial localization signals (MLS) (Bannai et al., 2002) . We have utilized 119 all the available tools for identification of the MLS of the FA proteins (Table S1A & B;   120 SuppleFig.S1.A, B and C). The iPSORT analysis predicted thirty amino acids at the N-terminal of 121 human FANCG protein as a mitochondrial localization signal (MLS) or Mitochondrial Targeting 122 Peptide (mTP) ( Fig.1A) . However, when we analyzed the N-terminal of FANCG of other species, 123 mTP was identified only in human FANCG ( Fig.1B & C) . For confirmation of this result, the 124 expression of the protein in a mammalian cell line is required. As the N-terminal thirty amino 125 acids were predicted as an MLS, we made several N-terminal deletion FANCG constructs 126 (05DEL, 09DEL, 18DEL, 24DEL, and MLSDEL {30 amino acids}) containing ATG sequences 127 as a start codon ( Fig. 1D ). All the deletion constructs were sequenced and confirmed to retain an 128 open reading frame. To visualize the FANCG expression in the cell line, the wild-type and the 129 deleted constructs were tagged with GFP at the C-terminal end. The mitochondrial marker Mito-Carl Zeiss; Axiovision software). The wild-type FANCG fused with GFP showed perfect co-134 localization with Mito-tracker in mitochondria of HeLa cells ( Fig.1D ). However, the deleted 135 constructs showed loss of co-localization with Mito-tracker ( Fig.1D ). The complete loss of co-136 localization was observed following deletion of 18, 24 and 30 amino acids (MLSDEL) ( Fig.1D ).
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These co-localization studies suggest that the in silico predicted N-terminal thirty amino acids are 138 the mitochondrial targeting Peptide (mTP) which actually determines the mitochondrial 139 localization of human FANCG.
140
Human mutant FANCGR22P lost mitochondrial localization, but not nuclear localization. 141 We further looked for pathogenic mutations in the MLS of FANCG. In the secondary structure, the MLS of FANCG is made with an alternate stretch of coil and helix. 150 The helix is interrupted by a coil in R22P due to replacement of arginine by proline ( Fig.2A ). In 151 our modeled structure, similarly, the MLS region of R22P is disrupted due to the replacement of 152 arginine by proline ( Fig.2B ). How the altered structure affects the mitochondrial migration is not with Cytochrome C (Fig.6E ). Thus, these results suggest that Cytochrome C did not migrate into 287 the matrix due to the loss of mitochondrial membrane potential. We have also studied the studies of FANCG in other species will be required to help explain this result. 316 We have identified several mutations in the MLS region of human FANCG from the LOVD, and 317 COSMIC (catalogue of somatic mutation in cancer) database and their mitochondrial localization 318 has been studied (unpublished results). In this report, we are describing one pathogenic mutation 319 where the 22 nd Arginine has been replaced by Proline (FANCGR22P). GFP expression of this 320 fusion construct suggests its inability to migrate into mitochondria. The predicted structure The inability of the cell to repair DNA damage may result in cancer. In this study, we have found 338 that despite the genomic DNA repair ability, the R22P patients are also affected by cancer 339 (LOVD database). R22P cells are highly sensitive to oxidative stress, and loss of mitochondrial 340 membrane potential is observed due to oxidative stress (Mukhopadhyay et al., 2006) . From these 341 two observations, we suggest that there is a correlation of the mitochondrial instability with 342 genomic instability. Many studies suggest that mitochondrial DNA mutation and loss of 343 mitochondrial membrane potential may cause cancer (Tokarz and Blasiak, 2014). One proposed 344 mechanism is that the reactive oxygen species (ROS) produced due to mitochondrial dysfunction 345 may destabilize the cellular macromolecules, including the damage of genomic DNA (Nunnari 346 and Suomalainen, 2012). So far, an association of oxidative stress with inter-strand cross-linking 347 (ICL) damage is not known. In order to elucidate this association, we performed an experiment 348 with R22P cells (Fig.5) . The results suggest that R22P cells can repair the ICL damage as long as 
% viable cells = [1.00 -(Number of blue cells ÷ Number of total cells)] × 100
Number of viable cells × 10 4 × 1.1 = cells/mL culture
The viable cells were used for the preparation of the graph at each concentration of the drug. 490 Triplicate experiments were performed for each concentration. 
